KATRINA SNIDER: Open Payments
NPI 1366894867 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 29 payments from 8 companies in 2025. Trend: 2023 $1,035 · 2024 $916 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $196 |
| Otsuka America Pharmaceutical, Inc. | 8 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $107 |
| Janssen Pharmaceuticals, Inc | 3 | $74 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Lundbeck LLC | 1 | $31 |
| ABBVIE INC. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: ARISTADA, ABILIFY ASIMTUFII, CAPLYTA, INVEGA SUSTENNA, REXULTI, COBENFY, VRAYLAR, UZEDY.
Industry payments across GA — which companies pay providers there.
